Thiotepa
- Product NDC
- 69539-124
- 11-digit product format
- 695390124
- Labeler code
- 69539
- Product ID
- 69539-124_1c6a2caa-abd7-4e8b-830f-e4fcf73e949a
- Type
- HUMAN PRESCRIPTION DRUG
- Nonproprietary name
- Thiotepa
- Dosage form
- INJECTION, POWDER, FOR SOLUTION
- Route
- INTRACAVITARY; INTRAVENOUS; INTRAVESICAL
- Labeler
- MSN LABORATORIES PRIVATE LIMITED
- Application
- ANDA213049
- Marketing category
- ANDA
- Marketing start
- 2020-03-04
- Marketing end
- 0000-00-00
- Substance
- THIOTEPA
- Active strength
- 100 mg/1
- Pharmacologic classes
- Alkylating Activity [MoA],Alkylating Drug [EPC]
- NDC exclude flag
- No
- Listing certified through
- 2021-12-31
- Current FDA listing
- Historical FDA.report record
FDA-Initiated Inactive NDC Indexing#
DailyMed Dashboard NDC Coverage#
NDC, Dashboard title, SPL version table| NDC | Dashboard title | SPL version | Validation | Dashboard ZIP |
|---|
| 69539-124 | THIOTEPA INJECTION, POWDER, FOR SOLUTION [MSN LABORATORIES PRIVATE LIMITED] | 3 | Legacy NDC | 20200309_6cb2e63c-1180-4201-b596-233d1b1a5dc8.zip |
Packages#
Package NDC, 11-digit format, Description table| Package NDC | 11-digit format | Description | Marketing start | Marketing end | Sample | Exclude flag | Status |
|---|
| 69539-124-01 | 69539012401 | 1 VIAL, GLASS in 1 BOX (69539-124-01) > 1 INJECTION, POWDER, FOR SOLUTION in 1 VIAL, GLASS | 2020-03-04 | 0000-00-00 | No | No | Current |